These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 26003640

  • 1. [Effect of continuous renal replacement therapy on the plasma concentration of imipenem in severe infection patients with acute renal injury].
    Yu B, Liu L, Xing D, Zhao C, Hu Z.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):359-65. PubMed ID: 26003640
    [Abstract] [Full Text] [Related]

  • 2. [The effect of AN69 ST membrane on filter lifetime in continuous renal replacement therapy without anticoagulation in patients with high risk of bleeding].
    Yin Y, Zhao C, Hu Z, Wei S, Huo Y.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):343-8. PubMed ID: 26003637
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of continuous veno venous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in critically ill patients with acute kidney injury].
    Wang H, Cui N, Zhou YK, Cheng W, Li L, Long Y, Liu DW.
    Zhonghua Nei Ke Za Zhi; 2018 Apr 01; 57(4):285-289. PubMed ID: 29614588
    [Abstract] [Full Text] [Related]

  • 5. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct 01; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA, Hudson JQ, Hill DM, Swanson JM, Wood GC, Laizure SC, Arnold-Ross A, Hu ZY, Hickerson WL.
    Pharmacotherapy; 2016 Dec 01; 36(12):1229-1237. PubMed ID: 27862103
    [Abstract] [Full Text] [Related]

  • 7. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL.
    Clin Ther; 2005 May 01; 27(5):599-608. PubMed ID: 15978309
    [Abstract] [Full Text] [Related]

  • 8. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, Winnock S, Montaudon D, Bedry R, Nouts C, Pillet O, Benissan GG, Favarel-Guarrigues JC, Castaing Y.
    Crit Care; 2003 Dec 01; 7(6):R160-6. PubMed ID: 14624691
    [Abstract] [Full Text] [Related]

  • 9. The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury.
    Dai X, Li T, Zeng Z, Fu C, Wang S, Cai Y, Chen Z.
    BMC Nephrol; 2016 Oct 19; 17(1):154. PubMed ID: 27760529
    [Abstract] [Full Text] [Related]

  • 10. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK, Foudraine NA, Burgers DM, Neef K, le Noble JL.
    Ther Drug Monit; 2016 Dec 19; 38(6):699-705. PubMed ID: 27494946
    [Abstract] [Full Text] [Related]

  • 11. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS, Matzke GR, Frye RF, Palevsky PM.
    Am J Kidney Dis; 1998 Jun 19; 31(6):1019-27. PubMed ID: 9631848
    [Abstract] [Full Text] [Related]

  • 12. [Effects of citric acid on patients with severe burn complicated with acute renal injury treated by continuous renal replacement therapy].
    Li XL, Xiao HT, Li YC, Li YG, Zhang J, Feng K, Di HP, Tian SM, Lou JH, Xia CD.
    Zhonghua Shao Shang Za Zhi; 2019 Aug 20; 35(8):568-573. PubMed ID: 31474035
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of the incidence and related factors of hypothermia in patients with continuous renal replacement therapy].
    Zhang P, Jiang H, Ye X, Fang K, Wang J, Yuan L, Zhang L, Lu W, Tao X, Jiang X.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Apr 20; 35(4):387-392. PubMed ID: 37308194
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, Saudan P.
    Crit Care; 2015 Mar 18; 19(1):91. PubMed ID: 25881975
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
    Fish DN, Teitelbaum I, Abraham E.
    Antimicrob Agents Chemother; 2005 Jun 18; 49(6):2421-8. PubMed ID: 15917542
    [Abstract] [Full Text] [Related]

  • 16. [Effects of regional citrate anticoagulation in continuous veno-venous hemofiltration of severe burn patients].
    Wang ZY, Feng SH, Fan BL, Ma W, Jia XC, Geng H.
    Zhonghua Shao Shang Za Zhi; 2021 Dec 20; 37(12):1137-1142. PubMed ID: 34839601
    [Abstract] [Full Text] [Related]

  • 17. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, González Chaparro LS, Gastelbondo Amaya R, Mulett Hoyos H, Tibaduiza D, Quintero Gómez AM.
    Pediatr Nephrol; 2017 Apr 20; 32(4):703-711. PubMed ID: 27896442
    [Abstract] [Full Text] [Related]

  • 18. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun 20; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 19. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
    Kalaria SN, Armahizer M, McCarthy P, Badjatia N, Gobburu JV, Gopalakrishnan M.
    Clin Transl Sci; 2020 Sep 20; 13(5):950-959. PubMed ID: 32223067
    [Abstract] [Full Text] [Related]

  • 20. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M, Hu B, Li Q, Liu J.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar 20; 28(3):246-51. PubMed ID: 29917340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.